BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 17879292)

  • 1. Rapid throughput screening of apparent KSP values for weakly basic drugs using 96-well format.
    Guo J; Elzinga PA; Hageman MJ; Herron JN
    J Pharm Sci; 2008 Jun; 97(6):2080-90. PubMed ID: 17879292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid throughput solubility screening method for BCS class II drugs in animal GI fluids and simulated human GI fluids using a 96-well format.
    Guo J; Elzinga PA; Hageman MJ; Herron JN
    J Pharm Sci; 2008 Apr; 97(4):1427-42. PubMed ID: 17724660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a partially automated solubility screening (PASS) assay for early drug development.
    Alsenz J; Meister E; Haenel E
    J Pharm Sci; 2007 Jul; 96(7):1748-62. PubMed ID: 17238197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a high throughput equilibrium solubility assay using miniaturized shake-flask method in early drug discovery.
    Zhou L; Yang L; Tilton S; Wang J
    J Pharm Sci; 2007 Nov; 96(11):3052-71. PubMed ID: 17722003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High throughput solubility measurement with automated polarized light microscopy analysis.
    Sugano K; Kato T; Suzuki K; Keiko K; Sujaku T; Mano T
    J Pharm Sci; 2006 Oct; 95(10):2115-22. PubMed ID: 16871512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of nephelometric, UV-spectroscopic, and HPLC methods for high-throughput determination of aqueous drug solubility in microtiter plates.
    Hoelke B; Gieringer S; Arlt M; Saal C
    Anal Chem; 2009 Apr; 81(8):3165-72. PubMed ID: 19317458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-throughput reactive oxygen species (ROS) assay: an enabling technology for screening the phototoxic potential of pharmaceutical substances.
    Onoue S; Igarashi N; Yamada S; Tsuda Y
    J Pharm Biomed Anal; 2008 Jan; 46(1):187-93. PubMed ID: 17935922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Development of solubility screening methods in drug discovery].
    Sugaya Y; Yoshiba T; Kajima T; Ishihama Y
    Yakugaku Zasshi; 2002 Mar; 122(3):237-46. PubMed ID: 11905048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A high-throughput screening method for the determination of aqueous drug solubility using laser nephelometry in microtiter plates.
    Bevan CD; Lloyd RS
    Anal Chem; 2000 Apr; 72(8):1781-7. PubMed ID: 10784141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of in silico models for estimating drug preformulation risk in PEG400/water and Tween80/water systems.
    Crivori P; Morelli A; Pezzetta D; Rocchetti M; Poggesi I
    Eur J Pharm Sci; 2007 Nov; 32(3):169-81. PubMed ID: 17714921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the light scattering and the turbidity microtiter plate-based methods for the detection of the excipient-mediated drug precipitation inhibition.
    Petruševska M; Urleb U; Peternel L
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1148-56. PubMed ID: 24056092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A high throughput solubility assay for drug discovery using microscale shake-flask and rapid UHPLC-UV-CLND quantification.
    Lin B; Pease JH
    J Pharm Biomed Anal; 2016 Apr; 122():126-40. PubMed ID: 26855285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integration of a rapid automated solubility classification into early validation of hits obtained by high throughput screening.
    Fligge TA; Schuler A
    J Pharm Biomed Anal; 2006 Oct; 42(4):449-54. PubMed ID: 16797909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Miniaturized assay for solubility and residual solid screening (SORESOS) in early drug development.
    Wyttenbach N; Alsenz J; Grassmann O
    Pharm Res; 2007 May; 24(5):888-98. PubMed ID: 17372689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COMDECOM: predicting the lifetime of screening compounds in DMSO solution.
    Zitha-Bovens E; Maas P; Wife D; Tijhuis J; Hu QN; Kleinöder T; Gasteiger J
    J Biomol Screen; 2009 Jun; 14(5):557-65. PubMed ID: 19483143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological assay challenges from compound solubility: strategies for bioassay optimization.
    Di L; Kerns EH
    Drug Discov Today; 2006 May; 11(9-10):446-51. PubMed ID: 16635808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High throughput UV method for the estimation of thermodynamic solubility and the determination of the solubility in biorelevant media.
    Bard B; Martel S; Carrupt PA
    Eur J Pharm Sci; 2008 Mar; 33(3):230-40. PubMed ID: 18207706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new expanded solubility parameter approach.
    Stefanis E; Panayiotou C
    Int J Pharm; 2012 Apr; 426(1-2):29-43. PubMed ID: 22260970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compound precipitation in high-concentration DMSO solutions.
    Popa-Burke I; Russell J
    J Biomol Screen; 2014 Oct; 19(9):1302-8. PubMed ID: 24980595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solvent shift method for anti-precipitant screening of poorly soluble drugs using biorelevant medium and dimethyl sulfoxide.
    Yamashita T; Ozaki S; Kushida I
    Int J Pharm; 2011 Oct; 419(1-2):170-4. PubMed ID: 21840385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.